Skip to content Skip to footer

Years bridging science & industry
0+
Target markets
0
Scientific expertise
0

WHAT WE DO

End-to-end commercialization for life sciences

We bridge the gap between academic research and industrial deployment. By combining PhD-level scientific judgment with global deal execution, we deliver the specialized market-entry support that neither a traditional consultancy nor a standard broker can provide.

Order online or request a custom quote

💡 Good to know: The €1,500 assessment fee is credited 100% against a Partner Sprint or Retainer if you proceed within 90 days.
Start Here
Entry Product · Order Online

Technology & IP Readiness Assessment

€1,500 (Single fixed price)
  • Commercial & IP readiness diagnostic
  • Freedom-to-operate / IP landscape scan
  • Clear Go / No-Go signal & tactical next steps
  • Comprehensive report + strategy review call
Order Online
Per Target Market

Partner & Licensing Sprint

From €4,500 (Depending on scope)
  • Target partner / licensee scouting in chosen market
  • Candidate qualification & strategic shortlist
  • Direct warm introductions to key decision-makers
  • Deal-structuring and negotiation guidance
Request a Quote
Monthly Retainer

Market Entry Advisory

From €2,500 / month
  • Dedicated market navigation (Japan · UK · Singapore)
  • Regulatory navigation & local partner liaison
  • On-the-ground operational project management
  • Ongoing executive steering support
Request a Quote
Accurate testing

Bridging the Gap Between the Academic Bench and Global Industry

We provide deep technical insight coupled with practical deal-making capability across our three core markets: Japan, the United Kingdom, and Singapore.

BioGlobal Connect operates at the intersection of rigorous scientific research and commercial execution. Founded on PhD-level scientific judgement and extensive cross-border experience, we eliminate the friction that keeps breakthrough biotechnology locked inside academic labs.

Questions & Answers

Frequently Asked Questions

BioGlobal Connect specializes in biotech technology transfer, intellectual property commercialization, and international market expansion. We partner with biotech startups, research institutions, and established life sciences companies looking to validate their intellectual property, license technologies, or scale into key global markets such as Japan, the UK, and Singapore.

Our entry-level fixed-price assessment (€1,500) provides a complete diagnostic of your asset’s commercial potential. It includes:

  • A commercial and IP readiness diagnostic

  • A targeted freedom-to-operate and IP landscape scan

  • A definitive Go / No-Go signal with tactical next steps

  • A comprehensive written report followed by an executive strategy review call

Yes. The €1,500 investment for the Technology & IP Readiness Assessment is 100% credited against any subsequent Partner Sprint or Monthly Retainer if you choose to proceed within 90 days.

Our Partner & Licensing Sprints are structured around your chosen target market. We manage the entire pipeline from end-to-end, including:

  • Target partner and licensee scouting

  • Candidate qualification and strategic shortlisting

  • Direct warm introductions to key industry decision-makers

  • Deal-structuring and negotiation advisory

You can begin immediately by ordering the Technology & IP Readiness Assessment directly online. If you require a bespoke multi-market strategy or ongoing support, select Request a Quote on any of our service tiers to discuss your specific project scope with our team.

Receive News

Subscribe for the Updates!

Receive News

Subscribe for the Updates!